Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition

Journal of Cardiovascular Pharmacology
H JinN F Paoni

Abstract

The effects of growth hormone (GH) plus insulin-like growth factor-1 (IGF-1) were tested in an experimental model of cardiac failure treated with chronic angiotensin-converting enzyme (ACE) inhibition. Myocardial infarction was induced in rats by left coronary artery ligation. Two weeks after ligation, the animals received either captopril (2 g/L in drinking water) or water for 3 months. The rats were then given either GH (2 mg/kg/day) plus IGF-1 (2 mg/kg/day) or vehicle for 14 days. Captopril treatment decreased mean arterial pressure (MAP), left ventricular end-diastolic pressure (LVEDP) and systemic vascular resistance (SVR) (p < 0.05), and increased cardiac index (CI) and stroke volume index (SVI) (p < 0.05). GH/IGF-1 or captopril+GH/IGF-1 treatment decreased MAP, LVEDP, and SVR (p < 0.05), and increased left ventricular maximum dP/dt, CI, and SVI (p < 0.05). The increases in CI and SVI were significantly greater in the captopril+GH/IGF-1-treated animals than in those treated with captopril alone (p < 0.05). The beneficial effect of captopril in reducing cardiac hypertrophy was preserved in the captopril+GH/IGF-1 group. The results indicate that GH/IGF-1 and captopril can improve cardiac performance in congestive heart fail...Continue Reading

Citations

Dec 13, 2001·European Journal of Pharmacology·J T MacAndrewS C Black
Feb 1, 2003·International Journal of Cardiology·Panagiotis E KontoleonJohn N Nanas
Dec 15, 2000·Progress in Pediatric Cardiology·A M MoranJ W Newburger
Aug 15, 2002·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Hongkui JinNicholas F Paoni
Aug 29, 1996·The New England Journal of Medicine·A FrustaciM A Russo
Sep 22, 2000·Pharmacotherapy·T M NgM A Munger
Jul 25, 2008·Journal of the American Society of Nephrology : JASN·Ralph RabkinMarie-Luise Gross
Jun 29, 2005·Treatments in Endocrinology·Annamaria ColaoGaetano Lombardi
Jul 30, 2005·Expert Opinion on Investigational Drugs·Catherine Demers, Robert S McKelvie
Feb 7, 2007·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Mukandila MulumbaSylvie Marleau
Aug 20, 2009·Cardiovascular Therapeutics·Parminder S ChaggarKevin S Channer
Apr 3, 2003·Congestive Heart Failure·Catherine Demers, Robert S McKelvie
Sep 25, 1999·Journal of Cardiac Failure·L Saccà
Nov 22, 2001·American Heart Journal·M K Al-ObaidiJ Alaghband-Zadeh
Jan 18, 2006·Biochemical and Biophysical Research Communications·Shiro YoshiokaKazuo Chihara
Sep 16, 2000·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·J Ross, T Ryoke
Jun 29, 2014·Endocrine·Jörgen IsgaardAntonio Cittadini
May 29, 1999·American Heart Journal·M R Johnson, M Gheorghiade
Aug 3, 1999·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·J Isgaard, A Tivesten
May 20, 2003·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Rachael G DeanLouise M Burrell
Feb 24, 2001·Clinical Endocrinology·A ColaoG Lombardi
Nov 22, 2000·American Journal of Physiology. Heart and Circulatory Physiology·H JinN F Paoni
Aug 24, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·A B NilssonP Friberg
Dec 7, 2019·International Journal of Cardiology·Manon BarutautPhilippe Rouet
Dec 12, 2001·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·A TivestenJ Isgaard
Dec 1, 1996·Journal of Cardiac Failure·J Ross, M Hongo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.